4/A
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-016097
Director acquired 2,011 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-11-16 | Other acquisition 10b5-1 | +66 | $1.73 | $114 | 227,925 | D |
| Krogulski Kenneth Director | 2023-11-17 | Other acquisition 10b5-1 | +280 | $1.83 | $512 | 228,205 | D |
| Krogulski Kenneth Director | 2023-11-20 | Other acquisition 10b5-1 | +268 | $1.70 | $456 | 228,473 | D |
| Krogulski Kenneth Director | 2023-11-21 | Other acquisition 10b5-1 | +125 | $1.76 | $220 | 228,598 | D |
| Krogulski Kenneth Director | 2023-11-22 | Other acquisition 10b5-1 | +280 | $1.74 | $487 | 228,878 | D |
| Krogulski Kenneth Director | 2023-11-27 | Other acquisition 10b5-1 | +379 | $1.86 | $705 | 229,257 | D |
| Krogulski Kenneth Director | 2023-11-28 | Other acquisition 10b5-1 | +124 | $1.68 | $208 | 229,381 | D |
| Krogulski Kenneth Director | 2023-11-29 | Other acquisition 10b5-1 | +165 | $1.73 | $285 | 229,546 | D |
| Krogulski Kenneth Director | 2023-11-30 | Other acquisition 10b5-1 | +324 | $1.66 | $538 | 229,870 | D |
Loading xslF345X05/marketforms-63722.xml…